Rutledge Ellis-Behnke, PhD

Rutledge Ellis-Behnke is Associate Director of the Technology Transfer Office at the University of Hong Kong, as well as Professor at the University's Li Ka Shing Faculty of Medicine: Department of Anatomy; State Key Lab for Brain and Cognitive Sciences; and Research Centre of Heart, Brain, Hormone and Healthy Aging.  He is also a Research Affiliate in the Brain and Cognitive Sciences department at MIT.  His primary interest is using nanobiotechnology to reconnect disconnected parts of the central nervous system (CNS).

He received his PhD in Neuroscience from MIT, BS from Rutgers University and graduated from Harvard Business School's International Senior Manager's Program (AMP/ISMP).

Prior to returning to school to pursue his PhD, Ellis-Behnke held various management positions including Senior Vice President of a public company for testing and consulting services and Co-founder/CEO in 1995 of one of the first internet companies to do online commerce in computer memory.

Ellis-Behnke is Associate Editor/Neurology for the journal Nanomedicine: Nanotechnology, Biology and Medicine, member of the Board of Directors and the Scientific Advisory Board for the Glaucoma Foundation, member of the China Spinal Cord Clinical Trial Network, Society for Neuroscience, American Chemical Society, Association for Research in Vision and Ophthalmology and Sigma Xi.

Technology Review named his nanotechnology discoveries one of the "Top 10 Emerging Technologies of 2007."

In addition to his work in neuroscience and nanomedicine Ellis-Behnke introduced the TabletPC to MIT and the University of Hong Kong as part of the migration to the paperless classroom to deliver all course material and tests to students digitally.